Filing Details

Accession Number:
0000875320-24-000158
Form Type:
4
Zero Holdings:
No
Publication Time:
2024-05-24 16:13:03
Reporting Period:
2024-05-22
Accepted Time:
2024-05-24 16:13:03
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
875320 Vertex Pharmaceuticals Inc / Ma VRTX Pharmaceutical Preparations (2834) 043039129
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1197036 I Bruce Sachs C/O Vertex Pharmaceuticals Incorporated
50 Northern Ave
Boston MA 02210
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2024-05-22 7,073 $93.51 47,073 No 4 M Direct
Common Stock Disposition 2024-05-22 7,073 $448.00 40,000 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Stock Option (Right to Buy) Disposition 2024-05-22 7,073 $0.00 7,073 $93.51
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
0 2026-05-31 No 4 M Direct
Footnotes
  1. Transaction made pursuant to Mr. Sachs' company approved trading plan under Rule 10b5-1, which was entered into on 02/12/2024.
  2. Fully vested.